ARCHIVES

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 22 | June 1, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Sends A Second Letter To Groups About Carboplatin

October 22, 2010

Frank Torti Named FDA Deputy Commissioner, To Take Leave As Wake Forest Center Director.

April 11, 2008

Single-Letter Mutation Found Responsible For Waldenstrom’s

December 30, 2011

No Constitutional Right To Experimental Drugs, Appeals Court Rules Against Abigail Alliance.

August 10, 2007

Karmanos Cancer Center Wins $4.6M From U.S. Army.

September 5, 2008

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

March 1, 2002